At What Age Should We Stop Colorectal Cancer Screening? When Is Enough, Enough?


Journal

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
ISSN: 1538-7755
Titre abrégé: Cancer Epidemiol Biomarkers Prev
Pays: United States
ID NLM: 9200608

Informations de publication

Date de publication:
09 01 2023
Historique:
received: 28 09 2022
revised: 01 11 2022
accepted: 22 11 2022
entrez: 9 1 2023
pubmed: 10 1 2023
medline: 11 1 2023
Statut: ppublish

Résumé

There is strong evidence that colorectal cancer screening can reduce both colorectal cancer incidence and mortality. Guidelines recommend screening for individuals age 45 to 75 years, but are less certain about the benefits after age 75 years. Dalmat and colleagues provide evidence that individuals with a prior negative colonoscopy 10 years or more prior to reaching age 76 to 85 years, had a low risk of colorectal cancer, and would be less likely to benefit from further screening. It is important to note that this study population did not include individuals with a family history of colon cancer or a personal history of having high-risk adenomas. These data suggest that a negative colonoscopy can be an effective risk-stratification tool when discussing further screening with elderly patients. See related article by Dalmat et al., p. 37.

Identifiants

pubmed: 36620899
pii: 712623
doi: 10.1158/1055-9965.EPI-22-1006
doi:

Types de publication

Editorial Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

6-8

Commentaires et corrections

Type : CommentOn

Informations de copyright

©2023 American Association for Cancer Research.

Auteurs

David Lieberman (D)

Division of Gastroenterology and Hepatology, Oregon Health and Science University L461, Portland, Oregon.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH